靶向噬菌体治疗：最新创新、临床应用和局限性

　　

   

   

图片:第六届噬菌体靶向治疗2023世界大会将于6月1日至2日在法国巴黎举行。    

图片来源:靶向噬菌体治疗会议

第六届噬菌体靶向治疗2023世界大会于6月1日至2日在法国巴黎举行，展示了与噬菌体和噬菌体治疗相关的所有方面。

它将重点介绍噬菌体的最新创新和临床应用，验证和局限性。《2023年巴黎靶向噬菌体疗法》还将涵盖噬菌体将如何改变未来的医学。

国际噬菌体治疗和传染病专家将介绍以下几点:

• 噬菌体治疗:最新进展与挑战

• 噬菌体的特性和分离

• 细菌与噬菌体的共同进化机制

• 噬菌体和微生物群:正在走向医学革命?

• 噬菌体预防和治疗应用

• 噬菌体，放射治疗和伤口愈合

噬菌体和微生物群:正在走向医学革命?  

与国际微生物学会(ISM)合作，一个会议将专门讨论噬菌体如何调节微生物群的质量和数量。我们还将讨论如何选择足够的噬菌体来靶向疾病中的微生物菌群失调。

学术的演讲者:    

Domenico Frezza, University of Roma Tor Vergata, Italy Phage Therapy: Vision and Gaps

Martha Clokie, University of Leicester, United Kingdom Phage Therapy & Its Applications: Where We Are Now and What’s Next?

William Summers, Yale University, USA  The History of Phage Therapy

Tristan Ferry, Hospices Civils de Lyon, France The Use of Bacteriophage Therapy for Complex Bacterial Infections: the PHAGEinLYON Experience

Anna Pistocchi, Università degli Studi di Milano, Italy Investigating the Therapeutic Potential of Phages as Antibacterials and Immunomodulators in a Zebrafish Model of Cystic Fibrosis

Rodrigo Ibarra Chavez, University of Copenhagen, Denmark Phage-inducible Chromosomal Islands Promote Genetic Variability by Blocking Phage Reproduction

Lilian Musila, U.S. Army Medical Research Directorate, Kenya Potential of Therapeutic Phages to Combat MDR ESKAPE Pathogens in Developing Nations

Jean-Paul Pirnay, Queen Astrid Military Hospital, Belgium Bacteriophages: It’s a medicine, Jim, but not as we know it

Aleksandra Petrovic Fabijan, Westmead Institute for Medical Research, Australia Therapeutic Monitoring of Phage Therapy

Noemi Poerio, University of Rome Tor Vergata, Italy A Novel Combined Host- and Pathogen-Directed Therapeutic Approach to Fight Infections by MDR- Klebsiella pneumoniae

Ryszard Mi?dzybrodzki, Hirszfeld Institute of Immunology and Experimental Therapy PAS, Poland Phages in the Medical Research Activity in Poland

Anders S. Nilsson, Stockholm University, Sweden Novel Computer Program for Modelling Bacteriophage Infection Kinetics

Farzaneh Moghtader, Istinye University, Turkey Combined Therapies for Severely Infected Wounds: Multifunctional Bio-hybrids Composed of Gelatine Microspheres Carrying Bacteriophages and/or bFGF and their Aggregates with Mesenchymal Stem Cells

Willem-Jan Metsemakers, KU Leuven, Belgium The Use of Bacteriophage Therapy for Difficult-to-Treat Musculoskeletal Infections: the PHAGEFORCE Experience

Mzia Kutateladze, Eliava Institute of Bacteriophage, Georgia Phage Therapy: History in the Soviet Unions and Potential Treatment of Human Infections

Industrials:

Alexander Sulakvelidze, President and CEO of Intralytix, Inc., USA Modern Approaches for Optimizing Therapeutic Phage Preparations

Jessica Sacher, cofounder of Phage Directory, Australia Scaling Phage Therapy, Starting with Phage Australia

David Jernigan, PhagenCorp, LLC, USA Inducing Native Phages From the Human Virome to Address Targeted Infections

Pranav Johri, Founder of Vitalis Phage Therapy, India From Patient to Advocate – Introducing Phage Therapy to India

展示你的创新:10分钟说服  

在2023年巴黎靶向噬菌体治疗期间，将有一个会议专门讨论噬菌体和噬菌体治疗领域的最新创新。

如果你是学者、实业家或创业公司代表，噬菌体疗法2023科学委员会邀请你在10分钟内展示你的最新创新。

机构合作伙伴    

本次会议是在国际微生物学会(ISM)的认可下组织的。